ASTC vs. PRE, RPID, AXDX, OMIC, TLIS, HLTH, PRPO, TBIO, HTGMQ, and BNGO
Should you be buying Astrotech stock or one of its competitors? The main competitors of Astrotech include Prenetics Global (PRE), Rapid Micro Biosystems (RPID), Accelerate Diagnostics (AXDX), Singular Genomics Systems (OMIC), Talis Biomedical (TLIS), Cue Health (HLTH), Precipio (PRPO), Telesis Bio (TBIO), HTG Molecular Diagnostics (HTGMQ), and Bionano Genomics (BNGO). These companies are all part of the "analytical instruments" industry.
Prenetics Global (NASDAQ:PRE) and Astrotech (NASDAQ:ASTC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation.
Astrotech received 123 more outperform votes than Prenetics Global when rated by MarketBeat users. However, 83.33% of users gave Prenetics Global an outperform vote while only 56.64% of users gave Astrotech an outperform vote.
Astrotech has lower revenue, but higher earnings than Prenetics Global. Astrotech is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.
Prenetics Global has a net margin of -193.60% compared to Prenetics Global's net margin of -550.25%. Astrotech's return on equity of -11.15% beat Prenetics Global's return on equity.
Prenetics Global has a beta of -0.28, suggesting that its share price is 128% less volatile than the S&P 500. Comparatively, Astrotech has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500.
In the previous week, Astrotech had 1 more articles in the media than Prenetics Global. MarketBeat recorded 4 mentions for Astrotech and 3 mentions for Prenetics Global. Astrotech's average media sentiment score of 1.54 beat Prenetics Global's score of 1.22 indicating that Prenetics Global is being referred to more favorably in the media.
Prenetics Global presently has a consensus target price of $9.00, indicating a potential upside of 50.25%. Given Astrotech's higher possible upside, equities analysts clearly believe Prenetics Global is more favorable than Astrotech.
25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 24.4% of Astrotech shares are held by institutional investors. 7.8% of Prenetics Global shares are held by company insiders. Comparatively, 11.5% of Astrotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Prenetics Global beats Astrotech on 11 of the 17 factors compared between the two stocks.
Get Astrotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ASTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Astrotech Competitors List
Related Companies and Tools
